Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia

Study examined the effectiveness of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia.